drug combination

199 articles

Survivor Stories
February 14, 2017 • 4 Min

Taking a Different Approach to Pancreatic Cancer Treatment

When Dr. Stephen Bigelsen was diagnosed with stage IV pancreatic cancer, he found a doctor to created a personalized treatment plan.

Completed Trials
June 14, 2019 • 2 Min

Testing a New Drug to Attack Pancreatic Tumor Blood Vessels

A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.

Completed Trials
October 10, 2016 • 2 Min

A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed

Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?

Completed Trials
April 5, 2017 • 2 Min

Comparing Chemotherapy and Radiation Regimens to Prevent Recurrence of Pancreatic Cancer

A clinical trial compares standard chemotherapy with gemcitabine to the combination of chemotherapy with capecitabine and radiation.

Survivor Stories
January 14, 2020 • 5 Min

At a Crossroads for Pancreatic Cancer Treatment

Ed O’Connor has been getting chemotherapy for his pancreatic cancer since 2016. His disease is stable and he has to decide whether to cut back on the chemo.

Completed Trials
June 30, 2016 • 2 Min

Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer

A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.

Completed Trials
September 12, 2018 • 3 Min

Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer

Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.

Completed Trials
June 15, 2017 • 2 Min

Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer

A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.

Completed Trials
November 2, 2017 • 2 Min

Testing a Breast Cancer Drug for Other Advanced Solid Tumors

In a clinical trial, a new class of breast cancer drug called a kinase inhibitor is being tested to treat pancreatic cancer.

Completed Trials
July 11, 2017 • 2 Min

Testing the Safety of a New Chemotherapy and Radiation Combination

A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.

Completed Trials
November 15, 2017 • 2 Min

Trying Targeted Treatments Used for Other Cancers

Researchers are trying kinase inhibitors that are effective for breast cancer, colorectal cancer, and melanoma on pancreatic cancer.

News
March 24, 2020 • 7 Min

Pancreatic Cancer Treatment During the COVID-19 Pandemic

During the March 2020 PancChat, pancreatic cancer experts discussed treatment during the COVID-19 pandemic, along with other important issues for patients.

Completed Trials
December 22, 2016 • 3 Min

A New Approach to Treating Some Advanced Pancreatic Cancer Patients

A clinical trial uses PEGPH20, a synthetic form of a human enzyme, to make treatment more effective in pancreatic cancer patients with high tumor pressure.

Completed Trials
April 3, 2016 • 2 Min

Comparing the Effectiveness of Vaccine Therapy With or Without Additional Immunotherapy

Can the immunotherapy combination of cancer vaccines and a checkpoint blockade drug work against metastatic pancreatic cancer?

Completed Trials
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.